koaguleringfaktorkoncentrat
Koaguleringfaktorkoncentrat, also known as clotting factor concentrate, are pharmaceutical preparations derived from human blood plasma or produced through recombinant DNA technology. These concentrates contain specific clotting factors that are deficient or defective in individuals with certain bleeding disorders, most notably hemophilia A and hemophilia B.
Hemophilia A is characterized by a deficiency in clotting factor VIII, while hemophilia B results from a
These concentrates can be used to treat active bleeding episodes, to prevent bleeding during surgery or invasive